Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 2032119-68-7 gadgvgksa in China, also supports custom service. Welcome to wholesale bulk high quality cas 2032119-68-7 gadgvgksa from our factory. Contact us for more details.
| Description | GADGVGKSA binds MHC and is recognized by T cells, often used in autoimmunity/tumor epitope studies; used for epitope mapping, immune monitoring and tetramers. |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| KRAS G12D (10-18) GADGVGKSA | KRAS G12D 10-18; GADGVGKSA | KRAS, G12D, neoantigen, cancer vaccine, epitope peptide | H-Gly-Ala-Asp-Gly-Val-Gly-Lys-Ser-Ala-OH | C30H52N10O13 | 760.37 | 760.8 | 以供应商COA为准(常用TFA盐) | 9 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-KRASG12D-01 | White to off-white powder | -20 °C, dry, protected from light, sealed storage | 2–8 °C for short-term storage; aliquot and freeze working solutions. | No Cys/Met/Trp/Tyr; good chemical stability. Contains Asp/Lys/Ser, moderate-to-good water solubility; soluble in water or DMSO-assisted dissolution. | Stable as powder under dry, sealed conditions. |
Functional Description
| Product Code | Frontend Short Summary | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Receptors |
| PEP-KRASG12D-01 | 9-mer neoantigen epitope from the KRAS G12D mutation, for tumor neoantigen vaccine and TCR-T/immunotherapy research. | The 10–18 neoantigen peptide (GADGVGKSA) arises from the human KRAS Gly12→Asp (G12D) driver mutation; compared with wild-type GAGGVGKSA it has an additional Asp at position 3, creating a novel MHC-binding epitope. Widely used in pan-cancer (pancreatic, colorectal, lung, etc.) neoantigen vaccine design, neoantigen-specific T-cell induction, TCR screening and tumor immunotherapy research. | Tumor neoantigens; KRAS G12D; cancer vaccines; immunotherapy; TCR-T | MHC class I (tumor neoantigen presentation) |
Hot Tags: cas 2032119-68-7 gadgvgksa, China cas 2032119-68-7 gadgvgksa manufacturers, suppliers, factory
